CoCensys Dropped From Nasdaq Listing
<i> Dow Jones</i>
CoCensys Inc.’s common stock was delisted from the Nasdaq national market, the Irvine company said Wednesday.
The stock had failed to sustain the $1 minimum price required for continued listing on the national market. The shares traded on the lower profile over-the-counter market, closing Wednesday at 81 cents.
CoCensys develops products for the treatment of neurological and psychiatric disorders.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
